PMC6668214_01
Images showing no evidence of PTB pre-treatment (A), while (B,C) show development of PTB during administration of nivolumab. (D) shows a follow-up radiological investigation demonstrating cancer progression. (A) Initial disease progression (2 Apr 2014). (B,C) PTB infection during nivolumab treatment (22 Apr 2016). (D) Progression of disease (9 May 2016).
fonc-09-00659-g0001.jpg
PMC6668214_01_fonc-09-00659-g0001.jpg
F1
She subsequently received 6 cycles of single-agent pemetrexed when her symptoms became significantly worse (Figure 1A) up to mid-2015. A CT scan of the chest showed evidence of progressive disease, with new nodules bilaterally as well as new features of lymphangitis carcinomatosis. (Figures 1B,C). Follow-up radiological investigation demonstrated cancer progression (Figure 1D).